ELV icon

Elevance Health

423.70 USD
-3.17
0.74%
Updated Apr 24, 10:45 AM EDT
1 day
-0.74%
5 days
8.64%
1 month
-0.83%
3 months
5.67%
6 months
1.11%
Year to date
15.82%
1 year
-20.62%
5 years
60.42%
10 years
174.63%
 

About: Elevance Health remains one of the leading health insurers in the US, providing medical benefits to 46 million medical members as of December 2024. The company offers employer, individual, and government-sponsored coverage plans. Elevance differs from its peers in its unique position as the largest single provider of Blue Cross Blue Shield branded coverage, operating as the licensee for the Blue Cross Blue Shield Association in 14 states. Through acquisitions, such as the Amerigroup deal in 2012 and MMM in 2021, Elevance's reach expands beyond those states through government-sponsored programs, such as Medicaid and Medicare Advantage plans, too. It is also an emerging player in pharmacy benefit management and other healthcare services.

Employees: 104,200

0
Funds holding %
of 7,419 funds
0
Analysts bullish %
of 9 analysts

Fund manager confidence

Based on 2024 Q4 regulatory disclosures by fund managers ($100M+ AUM)

1.23% more ownership

Funds ownership: 87.52% [Q3] → 88.75% (+1.23%) [Q4]

9% more call options, than puts

Call options by funds: $677M | Put options by funds: $619M

6% less funds holding

Funds holding: 1,665 [Q3] → 1,562 (-103) [Q4]

24% less first-time investments, than exits

New positions opened: 210 | Existing positions closed: 276

26% less funds holding in top 10

Funds holding in top 10: 50 [Q3] → 37 (-13) [Q4]

28% less capital invested

Capital invested by funds: $105B [Q3] → $75.9B (-$29B) [Q4]

36% less repeat investments, than reductions

Existing positions increased: 461 | Existing positions reduced: 721

Research analyst outlook

9 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
$405
4%
downside
Avg. target
$492
16%
upside
High target
$529
25%
upside

9 analyst ratings

positive
78%
neutral
22%
negative
0%
RBC Capital
Ben Hendrix
28% 1-year accuracy
19 / 67 met price target
13%upside
$478
Outperform
Reiterated
23 Apr 2025
Guggenheim
Jason Cassorla
7% 1-year accuracy
1 / 14 met price target
22%upside
$518
Buy
Reiterated
23 Apr 2025
Cantor Fitzgerald
Sarah James
25% 1-year accuracy
25 / 99 met price target
14%upside
$485
Overweight
Reiterated
23 Apr 2025
Barclays
Andrew Mok
28% 1-year accuracy
16 / 57 met price target
23%upside
$522
Overweight
Maintained
23 Apr 2025
Baird
Michael Ha
27% 1-year accuracy
6 / 22 met price target
25%upside
$529
Neutral
Downgraded
15 Apr 2025

Financial journalist opinion

Based on 25 articles about ELV published over the past 30 days

Negative
Seeking Alpha
18 hours ago
Elevance Health: Carelon Growth Not Fully Appreciated
Elevance Health, Inc.'s Q1 results showed stable Medicare utilization and reaffirmed guidance, in contrast to sector volatility following UnitedHealth Group's rough earnings miss. Medicaid pressures remain, but rate negotiations and targeted acquisitions may support margin recovery by 2026. Carelon Services is growing rapidly, offering diversification away from premium-driven revenue.
Elevance Health: Carelon Growth Not Fully Appreciated
Positive
Zacks Investment Research
1 day ago
Elevance Health's Q1 Earnings Beat Estimates on Rising Premiums
ELV continues to witness significant growth in Q1 revenues. However, its operating costs surge.
Elevance Health's Q1 Earnings Beat Estimates on Rising Premiums
Neutral
Seeking Alpha
1 day ago
Elevance Health, Inc. (ELV) Q1 2025 Earnings Call Transcript
Elevance Health, Inc. (NYSE:ELV ) Q1 2025 Earnings Conference Call April 22, 2025 8:30 AM ET Company Participants Nathan Rich - VP, IR Gail Boudreaux - President & CEO Mark Kaye - CFO Felicia Norwood - President, Government Health Benefits Pete Haytaian - President, Carelon Conference Call Participants A.J. Rice - UBS Lance Wilkes - Bernstein Stephen Baxter - Wells Fargo Andrew Mok - Barclays Lisa Gill - JPMorgan Ann Hynes - Mizuho Ryan Langston - TD Cowen Erin Wright - Morgan Stanley Ben Hendrix - RBC Capital Markets Josh Raskin - Nephron Research Sarah James - Cantor Fitzgerald Justin Lake - Wolfe Research Joanna Gajuk - Bank of America Securities George Hill - Deutsche Bank Whit Mayo - Leerink Partners Operator Ladies and gentlemen, thank you for standing by and welcome to the Elevance Health First Quarter Earnings Conference Call.
Elevance Health, Inc. (ELV) Q1 2025 Earnings Call Transcript
Neutral
Zacks Investment Research
2 days ago
Elevance Health (ELV) Reports Q1 Earnings: What Key Metrics Have to Say
While the top- and bottom-line numbers for Elevance Health (ELV) give a sense of how the business performed in the quarter ended March 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Elevance Health (ELV) Reports Q1 Earnings: What Key Metrics Have to Say
Positive
Zacks Investment Research
2 days ago
Elevance Health (ELV) Surpasses Q1 Earnings and Revenue Estimates
Elevance Health (ELV) came out with quarterly earnings of $11.97 per share, beating the Zacks Consensus Estimate of $11.21 per share. This compares to earnings of $10.64 per share a year ago.
Elevance Health (ELV) Surpasses Q1 Earnings and Revenue Estimates
Positive
Reuters
2 days ago
Elevance confirms quarterly profit beat, reaffirms 2025 forecast
Health insurer Elevance Health said on Tuesday its first-quarter profit came above Street expectations, matching the preliminary estimates it released last week after bellwether UnitedHealth's lowered full-year forecast triggered a selloff in the sector.
Elevance confirms quarterly profit beat, reaffirms 2025 forecast
Neutral
Business Wire
2 days ago
Elevance Health Reports First Quarter 2025 Results
INDIANAPOLIS--(BUSINESS WIRE)--Elevance Health, Inc. (NYSE: ELV) reported first quarter 2025 results. “At Elevance Health, our purpose—to improve the health of humanity—drives everything we do. In the first quarter, we made measurable progress reimagining the healthcare experience with personalized support, real-time digital solutions, and a whole-health model that improves outcomes and reduces cost. Through Carelon and our broader enterprise, we're delivering on our strategy to be a lifetime t.
Elevance Health Reports First Quarter 2025 Results
Positive
Reuters
6 days ago
Health insurer Elevance sees first-quarter profit above estimates
Elevance Health said on Thursday it expects first-quarter profit above estimates, helped by medical cost trends that were in line with its expectations.
Health insurer Elevance sees first-quarter profit above estimates
Positive
Zacks Investment Research
1 week ago
Will a Strong MA Business Aid Elevance Health's Q1 Earnings?
ELV's Q1 results are expected to reap the benefits of higher premiums from growing Medicare Advantage membership and acquisitions pursued within the Carelon unit.
Will a Strong MA Business Aid Elevance Health's Q1 Earnings?
Positive
Zacks Investment Research
1 week ago
Ahead of Elevance Health (ELV) Q1 Earnings: Get Ready With Wall Street Estimates for Key Metrics
Beyond analysts' top -and-bottom-line estimates for Elevance Health (ELV), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended March 2025.
Ahead of Elevance Health (ELV) Q1 Earnings: Get Ready With Wall Street Estimates for Key Metrics
Charts implemented using Lightweight Charts™